The next tranche will definitely be Zoetis.
Despite a difficult market environment, solid figures and well positioned with the veterinary medicine pipeline.
I think the share is currently trading below fair value and would take a chance on it.
The next tranche will definitely be Zoetis.
Despite a difficult market environment, solid figures and well positioned with the veterinary medicine pipeline.
I think the share is currently trading below fair value and would take a chance on it.